Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): A phase I/II study.

被引：0
|
作者：
Klautke, G
Foitzik, T
Ludwig, K
Klar, EJM
Fietkau, R
机构：
[1] Univ Rostock, Rostock, Germany
[2] Klinikum Sudstadt, Rostock, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3693
引用
收藏
页码：292S / 292S
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant chemoradiotherapy with capecitabine based regimen in locally advanced rectal cancer: A retrospective study
    Li, Fei
    Zhang, Chi
    Xu, Liping
    Zhang, Sheng
    Zhang, Dongsheng
    Leng, Yan
    Wu, Chenjiang
    Chen, Jiayan
    Sun, Xinchen
    MEDICINE, 2023, 102 (34) : E34985
  • [32] RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer
    Wong, S. J.
    Winter, K.
    Meropol, N. J.
    Anne, R.
    Kachnic, L. A.
    Rashid, A.
    Watson, J. C.
    Mitchell, E. P.
    Pollock, J.
    Lee, R. J.
    Willett, C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER
    Wong, Stuart J.
    Winter, Kathryn
    Meropol, Neal J.
    Anne, Pramila Rani
    Kachnic, Lisa
    Rashid, Asif
    Watson, James C.
    Mitchell, Edith
    Pollock, Jondavid
    Lee, Robert Jeffrey
    Haddock, Michael
    Erickson, Beth A.
    Willett, Christopher G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : 1367 - 1375
  • [34] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    Angiogenesis, 2012, 15 : 141 - 150
  • [35] A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    EJSO, 2010, 36 (03): : 244 - 250
  • [36] Phase II trial of capecitabine and irinotecan in combination with concurrent radiotherapy for neoadjuvant treatment of locally advanced rectal cancer.
    Willeke, F
    Tiefenbacher, U
    Hochhaus, A
    Wenz, F
    von Gerstenbergk, B
    Gnad-Vogt, U
    Horisberger, K
    Post, S
    Hofheinz, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 268S - 268S
  • [37] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Gasparini, Giampietro
    Torino, Francesco
    Ueno, Takayuki
    Cascinu, Stefano
    Troiani, Teresa
    Ballestrero, Alberto
    Berardi, Rossana
    Shishido, Junichi
    Yoshizawa, Akihiko
    Mori, Yukiko
    Nagayama, Satoshi
    Morosini, Paola
    Toi, Masakazu
    ANGIOGENESIS, 2012, 15 (01) : 141 - 150
  • [38] Neoadjuvant bevacizumab (BEV) combined with capecitabine (C) and standard radiation therpay (RT) in locally advanced rectal cancer (LARC): A phase II study
    Torino, F.
    Cascinu, S.
    Ciardiello, F.
    Ballestrero, A.
    Lencioni, M.
    Filippelli, G.
    Martignetti, A.
    Granetto, C.
    Sarmiento, R.
    Gasparini, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 57 - 57
  • [39] Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC).
    Shi, GG
    Lin, E
    Eng, C
    Delcos, M
    Crane, C
    Amos, CB
    Brown, T
    Abbruzzese, JL
    Skibber, J
    Janjan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
  • [40] PREOPERATIVE CHEMORADIATION WITH CETUXIMAB, IRINOTECAN, AND CAPECITABINE IN PATIENTS WITH LOCALLY ADVANCED RESECTABLE RECTAL CANCER: A MULTICENTER PHASE II STUDY
    Kim, Sun Young
    Hong, Yong Sang
    Kim, Dae Yong
    Kim, Tae Won
    Kim, Jee Hyun
    Im, Seok Ah
    Lee, Keun Seok
    Yun, Tak
    Jeong, Seung-Yong
    Choi, Hyo Seong
    Lim, Seok-Byung
    Chang, Hee Jin
    Jung, Kyung Hae
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 677 - 683
12345